Preliminary experiments reveal conolidine might inhibit precise ion channels, decreasing neuronal excitability and limiting soreness signals. This mechanism is particularly related in neuropathic pain, where abnormal signaling triggers persistent soreness. Also, conolidine seems to influence G protein-coupled receptor (GPCR) pathways integral to so